INCPF
Price:
$2.13
Market Cap:
$19.47B
InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder. The company is also developing ICP-192, a pan-FGFR inhibitor that is in a Phase I/...[Read more]
Industry
Biotechnology
IPO Date
2021-07-09
Stock Exchange
OTC
Ticker
INCPF
According to InnoCare Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 14.03B. This represents a change of 85.01% compared to the average of 7.58B of the last 4 quarters.
The mean historical Enterprise Value of InnoCare Pharma Limited over the last ten years is 8.71B. The current 14.03B Enterprise Value has changed 16.01% with respect to the historical average. Over the past ten years (40 quarters), INCPF's Enterprise Value was at its highest in in the June 2021 quarter at 26.51B. The Enterprise Value was at its lowest in in the March 2024 quarter at -175886540.87.
Average
8.71B
Median
9.87B
Minimum
3.78B
Maximum
12.36B
Discovering the peaks and valleys of InnoCare Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 48.83%
Maximum Annual Enterprise Value = 12.36B
Minimum Annual Increase = -63.60%
Minimum Annual Enterprise Value = 3.78B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 4.77B | 26.26% |
| 2023 | 3.78B | -63.60% |
| 2022 | 10.37B | -16.09% |
| 2021 | 12.36B | 48.83% |
| 2020 | 8.31B | -15.34% |
| 2019 | 9.81B | -1.17% |
| 2018 | 9.93B | -3.78% |
The current Enterprise Value of InnoCare Pharma Limited (INCPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.31B
5-year avg
7.92B
10-year avg
8.71B
InnoCare Pharma Limited’s Enterprise Value is less than Shanghai Junshi Biosciences Co., Ltd. (36.47B), greater than Genscript Biotech Corporation (4.47B), less than ALK-Abelló A/S (50.50B), greater than Laboratorios Farmaceuticos Rovi, S.A. (3.14B), less than Zealand Pharma A/S (29.02B), less than Camurus AB (publ) (32.57B), less than COSMOS Pharmaceutical Corporation (580.53B), greater than Fielmann AG (3.96B), less than Clicks Group Limited (82.99B), less than Gedeon Richter PLC (1.71T),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 36.47B | $5.81B | |
| 4.47B | $4.62B | |
| 50.50B | $7.26B | |
| 3.14B | $4.63B | |
| 29.02B | $5.62B | |
| 32.57B | $3.83B | |
| 580.53B | $3.83B | |
| 3.96B | $4.93B | |
| 82.99B | $4.90B | |
| 1.71T | $4.54B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoCare Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InnoCare Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is InnoCare Pharma Limited's Enterprise Value?
What is the highest Enterprise Value for InnoCare Pharma Limited (INCPF)?
What is the 3-year average Enterprise Value for InnoCare Pharma Limited (INCPF)?
What is the 5-year average Enterprise Value for InnoCare Pharma Limited (INCPF)?
How does the current Enterprise Value for InnoCare Pharma Limited (INCPF) compare to its historical average?